Company Peloton Therapeutics, Inc.
Equities
PLTX
US70614L1044
Biotechnology & Medical Research
Business Summary
Number of employees: 64
Managers
Managers | Title | Age | Since |
---|---|---|---|
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Corporate Officer/Principal | - | - | |
Peter Stenge
PRN | Corporate Officer/Principal | - | - |
Bronson Crouch
PRN | Corporate Officer/Principal | 51 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Helen Kim
BRD | Director/Board Member | 61 | 17-10-31 |
Brett A. Ringle
BRD | Director/Board Member | 73 | 10-12-31 |
David Chang
BRD | Director/Board Member | 64 | 18-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 44,461,361 | 0 | 0 | - |
Company contact information
Peloton Therapeutics, Inc.
2330 Inwood Road Suite 226
75235-7323, Dallas
+
http://www.pelotontherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+15.19% | 121B | |
+19.91% | 114B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B | |
+119.39% | 10.96B |